Company intelligence / Profile preview

Arava Bio Tech

Israel

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Arava Bio Tech develops and markets innovative pet skin and coat bio-care solutions, based on natural ingredients and Dead Sea minerals, aimed at protecting and promoting pet dermatological health through cleansing, anti-microbial, anti-parasitic, and conditioning products. There is no evidence of human clinical trials, advanced investigational drugs, or regulatory filings typical of pharma/biotech firms targeting human disease.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: Other (veterinary skin/coat care; likely topical, natural extracts, Dead Sea minerals)Natural extractsTopical dermatology formulations
Industry: Veterinary

Beyond the preview

Go deeper on Arava Bio Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arava Bio Tech.

Explore the full profile